Intensive care medicine
-
Intensive care medicine · Jul 2023
The effect of recombinant erythropoietin on long-term outcome after moderate-to-severe traumatic brain injury.
Recombinant erythropoietin (EPO) administered for traumatic brain injury (TBI) may increase short-term survival, but the long-term effect is unknown. ⋯ EPO neither decreased overall long-term mortality nor improved functional outcome in moderate or severe TBI patients treated in the intensive care unit (ICU). The limited sample size makes it difficult to make final conclusions about the use of EPO in TBI.